Damora Therapeutics
DMRA
#5408
Rank
C$2.06 B
Marketcap
C$33.30
Share price
-4.44%
Change (1 day)
40.82%
Change (1 year)

EPS for Damora Therapeutics (DMRA)

EPS in 2026 (TTM): C-$5.27

According to Damora Therapeutics's latest financial reports the company's current EPS (TTM) is C-$5.41. In 2025 the company made an earnings per share (EPS) of C-$5.71 an increase over its 2024 EPS that were of C-$26.57.

EPS history for Damora Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$5.27-7.65%
2025C-$5.71-78.52%
2024C-$26.57-48.64%
2023C-$51.74-40.61%
2022C-$87.1218.54%
2021C-$73.50-73.1%
2020C-$273.20131.17%
2019C-$118.1824.59%
2018C-$94.85